Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 295

1.

Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers.

Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC.

Angew Chem Int Ed Engl. 2014 Jul 2. doi: 10.1002/anie.201404766. [Epub ahead of print]

PMID:
24990548
[PubMed - as supplied by publisher]
2.

Suicidal ideation in prostate cancer survivors: Understanding the role of physical and psychological health outcomes.

Recklitis CJ, Zhou ES, Zwemer EK, Hu JC, Kantoff PW.

Cancer. 2014 Jun 24. doi: 10.1002/cncr.28880. [Epub ahead of print]

PMID:
24962506
[PubMed - as supplied by publisher]
3.

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T.

Small EJ, Higano CS, Kantoff PW, Whitmore JB, Frohlich MW, Petrylak DP.

Prostate Cancer Prostatic Dis. 2014 Jun 24. doi: 10.1038/pcan.2014.21. [Epub ahead of print]

PMID:
24957547
[PubMed - as supplied by publisher]
4.

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG positive prostate cancer.

Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2014 Jun 12. pii: cebp.0020.2014. [Epub ahead of print]

PMID:
24925673
[PubMed - as supplied by publisher]
5.

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.

Braunstein LZ, Chen MH, Loffredo M, Kantoff PW, D'Amico AV.

Prostate Cancer. 2014;2014:230812. doi: 10.1155/2014/230812. Epub 2014 Apr 22.

PMID:
24864213
[PubMed]
Free PMC Article
6.

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

Guancial EA, Werner L, Bellmunt J, Bamias A, Choueiri TK, Ross R, Schutz FA, Park RS, O'Brien RJ, Hirsch MS, Barletta JA, Berman DM, Lis R, Loda M, Stack EC, Garraway LA, Riester M, Michor F, Kantoff PW, Rosenberg JE.

Cancer Med. 2014 May 21. doi: 10.1002/cam4.262. [Epub ahead of print]

PMID:
24846059
[PubMed - as supplied by publisher]
7.

Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.

Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, Krajewski KM, Kantoff PW, Ross RW, Rosenberg JE.

J Clin Oncol. 2014 Jun 20;32(18):1889-94. doi: 10.1200/JCO.2013.52.4785. Epub 2014 May 12.

PMID:
24821883
[PubMed - in process]
8.

Prostate cancer, version 2.2014.

Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M.

J Natl Compr Canc Netw. 2014 May;12(5):686-718.

PMID:
24812137
[PubMed - in process]
9.

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.

Hsieh CL, Fei T, Chen Y, Li T, Gao Y, Wang X, Sun T, Sweeney CJ, Lee GS, Chen S, Balk SP, Liu XS, Brown M, Kantoff PW.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.

PMID:
24778216
[PubMed - indexed for MEDLINE]
10.

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, Francis JM, Zhang CZ, Shalek AK, Satija R, Trombetta JJ, Lu D, Tallapragada N, Tahirova N, Kim S, Blumenstiel B, Sougnez C, Lowe A, Wong B, Auclair D, Van Allen EM, Nakabayashi M, Lis RT, Lee GS, Li T, Chabot MS, Ly A, Taplin ME, Clancy TE, Loda M, Regev A, Meyerson M, Hahn WC, Kantoff PW, Golub TR, Getz G, Boehm JS, Love JC.

Nat Biotechnol. 2014 May;32(5):479-84. doi: 10.1038/nbt.2892. Epub 2014 Apr 20.

PMID:
24752078
[PubMed - in process]
11.

Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators.

Martin NE, Chen MH, Beard CJ, Nguyen PL, Loffredo MJ, Renshaw AA, Kantoff PW, D'Amico AV.

Prostate Cancer. 2014;2014:912943. doi: 10.1155/2014/912943. Epub 2014 Feb 20.

PMID:
24701353
[PubMed]
Free PMC Article
12.

SPINK1 Protein Expression and Prostate Cancer Progression.

Flavin RJ, Pettersson A, Hendrickson WK, Fiorentino M, Finn SP, Kunz L, Judson G, Lis RT, Bailey D, Fiore C, Nuttall EJ, Martin NE, Stack EC, Penney KL, Rider JR, Sinnott JA, Sweeney CS, Sesso HD, Fall K, Giovannucci EL, Kantoff PW, Stampfer MJ, Loda M, Mucci LA.

Clin Cancer Res. 2014 Mar 31. [Epub ahead of print]

PMID:
24687926
[PubMed - as supplied by publisher]
13.

Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.

Sharma J, Gray KP, Harshman LC, Evan C, Nakabayashi M, Fichorova R, Rider J, Mucci L, Kantoff PW, Sweeney CJ.

Prostate. 2014 Jun;74(8):820-8. doi: 10.1002/pros.22788. Epub 2014 Mar 26.

PMID:
24668612
[PubMed - indexed for MEDLINE]
14.

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Wagle N, Grabiner BC, Van Allen EM, Hodis E, Jacobus S, Supko JG, Stewart M, Choueiri TK, Gandhi L, Cleary JM, Elfiky AA, Taplin ME, Stack EC, Signoretti S, Loda M, Shapiro GI, Sabatini DM, Lander ES, Gabriel SB, Kantoff PW, Garraway LA, Rosenberg JE.

Cancer Discov. 2014 May;4(5):546-53. doi: 10.1158/2159-8290.CD-13-0353. Epub 2014 Mar 13.

PMID:
24625776
[PubMed - in process]
15.

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease.

Keane FK, Chen MH, Zhang D, Loffredo MJ, Kantoff PW, Renshaw AA, D'Amico AV.

Cancer. 2014 Jun 15;120(12):1787-93. doi: 10.1002/cncr.28609. Epub 2014 Mar 6.

PMID:
24604289
[PubMed - in process]
16.

Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.

Yao X, Choudhury AD, Yamanaka YJ, Adalsteinsson VA, Gierahn TM, Williamson CA, Lamb CR, Taplin ME, Nakabayashi M, Chabot MS, Li T, Lee GS, Boehm JS, Kantoff PW, Hahn WC, Wittrup KD, Love JC.

Integr Biol (Camb). 2014 Apr;6(4):388-98. doi: 10.1039/c3ib40264a. Epub 2014 Feb 13.

PMID:
24522233
[PubMed - in process]
17.

Population-based patterns of prescription androgen use, 1976-2008.

Hall SA, Ranganathan G, Tinsley LJ, Lund JL, Kupelian V, Wittert GA, Kantoff PW, Morales A, Araujo AB.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):498-506. doi: 10.1002/pds.3579. Epub 2014 Feb 7.

PMID:
24510484
[PubMed - in process]
18.

Effects of a gift certificate incentive and specialized delivery on prostate cancer survivors' response rate to a mailed survey: a randomized-controlled trial.

Bakan J, Chen B, Medeiros-Nancarrow C, Hu JC, Kantoff PW, Recklitis CJ.

J Geriatr Oncol. 2014 Apr;5(2):127-32. doi: 10.1016/j.jgo.2013.11.005. Epub 2013 Dec 17.

PMID:
24495697
[PubMed - in process]
19.

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Riester M, Werner L, Bellmunt J, Selvarajah S, Guancial EA, Weir BA, Stack EC, Park RS, O'Brien R, Schutz FA, Choueiri TK, Signoretti S, Lloreta J, Marchionni L, Gallardo E, Rojo F, Garcia DI, Chekaluk Y, Kwiatkowski DJ, Bochner BH, Hahn WC, Ligon AH, Barletta JA, Loda M, Berman DM, Kantoff PW, Michor F, Rosenberg JE.

Clin Cancer Res. 2014 Apr 1;20(7):1873-83. doi: 10.1158/1078-0432.CCR-13-0759. Epub 2014 Jan 31.

PMID:
24486590
[PubMed - in process]
20.

Prostate cancer, version 1.2014.

Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kawachi MH, Kuettel M, Lee RJ, Macvicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Small EJ, Srinivas S, Stein C, Strope SA, Tward J, Walsh PC, Shead DA, Ho M.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1471-9.

PMID:
24335682
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk